15 results on '"Crepaldi F"'
Search Results
2. Primary hepatic lymphoma: a monoinstitutional experience
- Author
-
Crepaldi, F., primary, Bocci, B., additional, Blasi, M., additional, Careri, C., additional, Patanè, D., additional, Viale, G., additional, Violati, M., additional, Bordin, V., additional, Codecà, C., additional, Moro, A., additional, Foa, P., additional, Santambrogio, R., additional, and Ferrari, D., additional
- Published
- 2016
- Full Text
- View/download PDF
3. Radiotherapy and cetuximab for elderly patients affected by loco-regionally advanced head and neck cancer
- Author
-
Ferrari, D., primary, Codecà, C., additional, Bocci, B., additional, Crepaldi, F., additional, Careri, C., additional, Blasi, M., additional, Patanè, D., additional, Viale, G., additional, Violati, M., additional, Bordin, V., additional, Caldiera, S., additional, Luciani, A., additional, Zonato, S., additional, and Foa, P., additional
- Published
- 2016
- Full Text
- View/download PDF
4. Intensity-modulated radiotherapy and cetuximab for frail patients with loco-regionally advanced head and neck cancer
- Author
-
Bocci, B., primary, Broggio, F., additional, Crepaldi, F., additional, Violati, M., additional, Battisti, N., additional, Careri, C., additional, Bordin, V., additional, Caldiera, S., additional, Codecà, C., additional, Luciani, A., additional, Zonato, S., additional, Cassinelli, G., additional, Foa, P., additional, and Ferrari, D., additional
- Published
- 2015
- Full Text
- View/download PDF
5. Role of PET/TC in the pre-surgery staging of oral cavity cancers
- Author
-
Broggio, F., primary, Crepaldi, F., additional, Bocci, B., additional, Violati, M., additional, Battisti, N., additional, Careri, C., additional, Caldiera, S., additional, Codecà, C., additional, Bordin, V., additional, Luciani, A., additional, Zonato, S., additional, Cassinelli, G., additional, Foa, P., additional, and Ferrari, D., additional
- Published
- 2015
- Full Text
- View/download PDF
6. Concordance of PET/CT and bone marrow biopsy in lymphoma staging
- Author
-
Crepaldi, F., primary, Broggio, F., additional, Bocci, B., additional, Careri, C., additional, Battisti, N., additional, Violati, M., additional, Bordin, V., additional, Caldiera, S., additional, Codecà, C., additional, Luciani, A., additional, Zonato, S., additional, Cassinelli, G., additional, Foa, P., additional, and Ferrari, D., additional
- Published
- 2015
- Full Text
- View/download PDF
7. S49 - Primary hepatic lymphoma: a monoinstitutional experience
- Author
-
Crepaldi, F., Bocci, B., Blasi, M., Careri, C., Patanè, D., Viale, G., Violati, M., Bordin, V., Codecà, C., Moro, A., Foa, P., Santambrogio, R., and Ferrari, D.
- Published
- 2016
- Full Text
- View/download PDF
8. L12 - Radiotherapy and cetuximab for elderly patients affected by loco-regionally advanced head and neck cancer
- Author
-
Ferrari, D., Codecà, C., Bocci, B., Crepaldi, F., Careri, C., Blasi, M., Patanè, D., Viale, G., Violati, M., Bordin, V., Caldiera, S., Luciani, A., Zonato, S., and Foa, P.
- Published
- 2016
- Full Text
- View/download PDF
9. Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial
- Author
-
F. Negri, Emanuela Scarpi, Giovanna Luchena, Sara Alquati, Alessandro Comandone, Silvia Quadrini, Maria Simona Pino, Angela Buonadonna, Maria Grazia Rodriquenz, Ferdinando Garetto, Monica Giordano, Rodolfo Scognamiglio, Giovanni Luca Frassineti, Marina Faedi, Paolo Pedrazzoli, Roberta Gauna, Silvia Ruscelli, Massimo Costantini, Chiara Broglia, Filomena Narducci, Antonella Galiano, Sonia Zoccali, Chiara Cifatte, Daniela Degiovanni, Massimo Luzzani, Monia Dall'Agata, Alberto Farolfi, Raffaella Bertè, Vittorina Zagonel, Dino Amadori, Elena Amaducci, Elisabetta Sansoni, Pietro Sozzi, Maria Teresa Cattaneo, Daris Ferrari, Andrea Casadei Gardini, Francesca Crepaldi, Martina Valgiusti, Roberto Bortolussi, Cristina Pittureri, Rosa Porzio, Cataldo Mastromauro, Alfina Bramanti, Angela Ragazzini, Marco Maltoni, Luigi Montanari, Leonardo Trentin, Carla Codecà, Augusto Caraceni, Gino Crivellari, Oriana Nanni, Davide Dalu, Sara Pini, Claudia Biasini, Maltoni, Marco, Scarpi, Emanuela, Dall'Agata, Monia, Zagonel, Vittorina, Bertè, Raffaella, Ferrari, Dari, Broglia, Chiara Maria, Bortolussi, Roberto, Trentin, Leonardo, Valgiusti, Martina, Pini, Sara, Farolfi, Alberto, Casadei Gardini, Andrea, Nanni, Oriana, Amadori, Dino, Frassineti, Giovanni Luca, Sansoni, Elisabetta, Ragazzini, Angela, Ruscelli, Silvia, Crivellari, Gino, Galiano, Antonella, Rodriquenz, Maria Grazia, Biasini, Claudia, Porzio, Rosa, Pittureri, Cristina, Amaducci, Elena, Faedi, Marina, Codecà, Carla, Crepaldi, Francesca, Pedrazzoli, Paolo, Bramanti, Alfina, Buonadonna, Angela, Garetto, Ferdinando, Comandone, Alessandro, Giordano, Monica, Luchena, Giovanna, Luzzani, Massimo, Cifatte, Chiara, Pino, Maria Simona, Zoccali, Sonia, Cattaneo, Maria Teresa, Dalu, Davide, Sozzi, Pietro, Gauna, Roberta, Alquati, Sara, Costantini, Massimo, Quadrini, Silvia, Narducci, Filomena, Mastromauro, Cataldo, Scognamiglio, Rodolfo, Degiovanni, Daniela, Negri, Federica, Caraceni, Augusto, Montanari, Luigi, Maltoni M., Scarpi E., Dall'Agata M., Zagonel V., Berte R., Ferrari D., Broglia C.M., Bortolussi R., Trentin L., Valgiusti M., Pini S., Farolfi A., Casadei Gardini A., Nanni O., Amadori D., Frassineti G.L., Sansoni E., Ragazzini A., Ruscelli S., Crivellari G., Galiano A., Rodriquenz M.G., Biasini C., Porzio R., Pittureri C., Amaducci E., Faedi M., Codeca C., Crepaldi F., Pedrazzoli P., Bramanti A., Buonadonna A., Garetto F., Comandone A., Giordano M., Luchena G., Luzzani M., Cifatte C., Pino M.S., Zoccali S., Cattaneo M.T., Dalu D., Sozzi P., Gauna R., Alquati S., Costantini M., Quadrini S., Narducci F., Mastromauro C., Scognamiglio R., Degiovanni D., Negri F., Caraceni A., and Montanari L.
- Subjects
Adult ,Male ,Quality of life ,medicine.medical_specialty ,Cancer Research ,Palliative care ,Anxiety ,03 medical and health sciences ,0302 clinical medicine ,Early palliative care ,On demand ,Internal medicine ,Pancreatic cancer ,Humans ,Medicine ,Prospective Studies ,030212 general & internal medicine ,Patient Comfort ,Aged ,Quality of Health Care ,Aged, 80 and over ,Depression ,business.industry ,Palliative Care ,Quality of care ,Cancer ,Oncology ,Middle Aged ,medicine.disease ,Confidence interval ,Pancreatic Neoplasms ,Clinical trial ,030220 oncology & carcinogenesis ,Physical therapy ,Female ,business ,Cancer pain - Abstract
Background Early palliative care (EPC) in oncology has been shown to have a positive impact on clinical outcome, quality-of-care outcomes, and costs. However, the optimal way for activating EPC has yet to be defined. Methods This prospective, multicentre, randomised study was conducted on 207 outpatients with metastatic or locally advanced inoperable pancreatic cancer. Patients were randomised to receive ‘standard cancer care plus on-demand EPC’ (n=100) or ‘standard cancer care plus systematic EPC’ (n=107). Primary outcome was change in quality of life (QoL) evaluated through the Functional Assessment of Cancer Therapy – Hepatobiliary questionnaire between baseline (T0) and after 12 weeks (T1), in particular the integration of physical, functional, and Hepatic Cancer Subscale (HCS) combined in the Trial Outcome Index (TOI). Patient mood, survival, relatives' satisfaction with care, and indicators of aggressiveness of care were also evaluated. Findings The mean changes in TOI score and HCS score between T0 and T1 were −4.47 and −0.63, with a difference between groups of 3.83 (95% confidence interval [CI] 0.10–7.57) (p=0.041), and −2.23 and 0.28 (difference between groups of 2.51, 95% CI 0.40–4.61, p=0.013), in favour of interventional group. QoL scores at T1 of TOI scale and HCS were 84.4 versus 78.1 (p=0.022) and 52.0 versus 48.2 (p=0.008), respectively, for interventional and standard arm. Until February 2016, 143 (76.9%) of the 186 evaluable patients had died. There was no difference in overall survival between treatment arms. Interpretations Systematic EPC in advanced pancreatic cancer patients significantly improved QoL with respect to on-demand EPC.
- Published
- 2016
10. Orangutans and chimpanzees produce morphologically varied laugh facesin response to the age and sex of their social partners.
- Author
-
Crepaldi F, Rocque F, Dezecache G, Proops L, and Davila-Ross M
- Subjects
- Animals, Female, Male, Laughter, Pongo physiology, Age Factors, Social Behavior, Humans, Sex Factors, Pan troglodytes physiology, Facial Expression
- Abstract
Laugh faces of humans play a key role in everyday social interactions as a pervasive tool of communication across contexts. Humans often vary the degree of mouth opening and teeth exposure when producing these facial expressions, which may depend on who their social partner is (e.g., their gender and age as well as their social relationship), serving this way different functions. Although it was found that laugh faces show evolutionary continuity across humans and non-human great apes according to the Principle of Maximum Parsimony, little is known about the function of laugh face variations from an evolutionary perspective. Hence, the present work examined the morphology of laugh faces in orangutan and chimpanzee dyadic play to test if they are modified with dependence on the playmate's characteristics (sex, age and social relationship). In total, we analysed over 600 facial expressions of 14 orangutans and 17 chimpanzees by coding the specific muscle activations (Action Units, i.e. AUs) contributing to these expressions, using OrangFACS and ChimpFACS, respectively. Our results suggest that age difference and, to a lesser extent, playmate sex influence laugh face morphology in both taxa, but in opposite ways. While the orangutans of our study seem to expose their upper teeth (with AU10) and to pull the mouth corners (with AU12) more towards weaker partners (younger and female), possibly to communicate non-hostility, the chimpanzees showed both upper and lower teeth exposure (with AU10 and AU16) more often when interacting with the stronger partners (older individuals), possibly to communicate submissiveness. These findings suggest that the ability of humans to modify laugh faces with dependence on social partner characteristics has most likely evolved from pre-existing traits, going back at least to the last common ancestor of today's great apes, including humans., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
11. Temporary Shutdown of ERK1/2 Phosphorylation Is Associated With Activation of Adaptive Immune Cell Responses and Disease Progression During Leishmania amazonensis Infection in BALB/c Mice.
- Author
-
Oliveira LG, Souza-Testasicca MC, Ricotta TNQ, Vago JP, Dos Santos LM, Crepaldi F, Lima KM, Queiroz-Junior C, Sousa LP, and Fernandes AP
- Subjects
- Animals, Biomarkers, Cytokines metabolism, Disease Models, Animal, Disease Progression, Female, Host-Pathogen Interactions immunology, Inflammation Mediators metabolism, Leishmaniasis pathology, Mice, Parasite Load, Phagocytosis immunology, Phosphorylation, Signal Transduction, Immunity, Cellular, Leishmania mexicana immunology, Leishmaniasis immunology, Leishmaniasis metabolism, Leishmaniasis parasitology, Mitogen-Activated Protein Kinase 1 metabolism, Mitogen-Activated Protein Kinase 3 metabolism
- Abstract
Leishmania spp. infection outcomes are dependent on both host and parasite factors. Manipulation of host signaling pathways involved in the generation of immune responses is thought to be one of the most common mechanisms used by parasites for persistence within the host. Considering the diversity of pathologies caused by different Leishmania spp., it is plausible that significant differences may exist in the mechanisms of host cell manipulation by each parasite species, which may have implications when developing new vaccine or treatment strategies. Here we show that in L. braziliensis -infection in BALB/c mice, a model of resistance, activation of ERK1/2 coincides with the peak of inflammatory responses and resolution of tissue parasitism. In contrast, in the susceptibility model of L. amazonensis -infection, an early silent phase of infection is observed, detected solely by quantification of parasite loads. At this early stage, only basal levels of P-ERK1/2 are observed. Later, after a brief shutdown of ERK1/2 phosphorylation, disease progression is observed and is associated with increased inflammation, lesion size and tissue parasitism. Moreover, the short-term down-regulation of ERK1/2 activation affected significantly downstream inflammatory pathways and adaptive T cell responses. Administration of U0126, a MEK/ERK inhibitor, confirmed this phenomenon, since bigger lesions and higher parasite loads were seen in infected mice that received U0126. To investigate how kinetics of ERK1/2 activation could affect the disease progression, U0126 was administered to L. amazonensis -infected animals earlier than the P-ERK1/2 switch off time-point. This intervention resulted in anticipation of the same effects on inflammatory responses and susceptibility phenotype seen in the natural course of infection. Additionally, in vitro inhibition of ERK1/2 affected the phagocytosis of L. amazonensis by BMDMs. Collectively, our findings reveal distinct temporal patterns of activation of inflammatory responses in L. braziliensis and L. amazonensis in the same animal background and a pivotal role for a brief and specific shutdown of ERK1/2 activation at late stages of L. amazonensis infection. Since activation of inflammatory responses is a crucial aspect for the control of infectious processes, these findings may be important for the search of new and specific strategies of vaccines and treatment for tegumentary leishmaniasis., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Oliveira, Souza-Testasicca, Ricotta, Vago, dos Santos, Crepaldi, Lima, Queiroz-Junior, Sousa and Fernandes.)
- Published
- 2022
- Full Text
- View/download PDF
12. Differential expression of Acanthamoeba castellanii proteins during amoebic keratitis in rats.
- Author
-
Carvalho-Silva AC, Coelho CH, Cirelli C, Crepaldi F, Rodrigues-Chagas IA, Furst C, Pimenta DC, Toledo JS, Fernandes AP, and Costa AO
- Subjects
- Acanthamoeba Keratitis parasitology, Analysis of Variance, Animals, Disease Models, Animal, Humans, Male, Proteomics, Protozoan Proteins genetics, Rats, Rats, Wistar, Spectrometry, Mass, Electrospray Ionization, Two-Dimensional Difference Gel Electrophoresis, Acanthamoeba Keratitis metabolism, Acanthamoeba castellanii metabolism, Protozoan Proteins biosynthesis
- Abstract
Amoebic keratitis (AK) is a sight-threatening infection characterized by a severe inflammation of the cornea, caused by the free-living protozoan of the genus Acanthamoeba. Identification of amoebic proteins involved in AK pathogenesis may help to elucidate molecular mechanisms of infection and contribute to indicate diagnostic and therapeutic targets. In this study, we evaluated changes in the expression profile of Acanthamoeba proteins triggered by the invasive process, using an approach involving two-dimensional polyacrylamide gel electrophoresis (2DE PAGE), followed by mass spectrometry identification (ESI-IT-TOF LC-MSn). AK was induced by intrastromal inoculation in Wistar rats, using trophozoites from a T4 genotype, human case-derived A. castellanii strain under prolonged axenic culture. Cultures re-isolated from the lesions after two successive passages in the animals were used as biological triplicate for proteomic experiments. Analysis of the protein profile comparing long-term and re-isolated cultures indicated 62 significant spots, from which 27 proteins could be identified in the Acanthamoeba proteome database. Five of them (Serpin, Carboxypeptidase A1, Hypothetical protein, Calponin domain-containing protein, aldo/keto reductase) were exclusively found in the re-isolated trophozoites. Our analysis also revealed that a concerted modulation of several biochemical pathways is triggered when A. castellanii switches from a free-living style to a parasitic mode, including energetic metabolism, proteolytic activity, control of gene expression, protein degradation and methylation of DNA, which may be also involved in gain of virulence in an animal model of AK., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
13. Mapping Alterations Induced by Long-Term Axenic Cultivation of Leishmania amazonensis Promastigotes With a Multiplatform Metabolomic Fingerprint Approach.
- Author
-
Crepaldi F, de Toledo JS, do Carmo AO, Ferreira Marques Machado L, de Brito DDV, Serufo AV, Almeida APM, de Oliveira LG, Ricotta TQN, Moreira DS, Murta SMF, Diniz AB, Menezes GB, López-Gonzálvez Á, Barbas C, and Fernandes AP
- Subjects
- Animals, Chromatography, High Pressure Liquid, Computational Biology, Female, Gas Chromatography-Mass Spectrometry, Interferon-gamma, Leishmania classification, Leishmaniasis parasitology, Mice, Oxidative Stress, Reactive Oxygen Species, Leishmania metabolism, Metabolome, Metabolomics methods
- Abstract
Leishmaniases are widespread neglected diseases with an incidence of 1.6 million new cases and 40 thousand deaths per year. Leishmania parasites may show distinct, species-specific patterns of virulence that lead to different clinical manifestations. It is well known that successive in vitro passages (SIVP) lead to the attenuation of virulence, but neither the metabolism nor the pathways involved in these processes are well understood. Herein, promastigotes of a virulent L. amazonensis strain recently isolated from mice was compared to SIVP derived and attenuated promastigotes, submitted to 10, 40, and 60 axenic passages and named R10, R40, and R60, respectively. In vitro assays and in vivo tests were performed to characterize and confirmed the attenuation profiles. A metabolomic fingerprint comparison of R0, R10, and R60 was performed by means of capillary electrophoresis, liquid and gas chromatography coupled to mass spectrometry. To validate the metabolomic data, qPCR for selected loci, flow cytometry to measure aPS exposure, sensitivity to antimony tartrate and ROS production assays were conducted. The 65 identified metabolites were clustered in biochemical categories and mapped in eight metabolic pathways: ABC transporters; fatty acid biosynthesis; glycine, serine and threonine metabolism; β-alanine metabolism; glutathione metabolism; oxidative phosphorylation; glycerophospholipid metabolism and lysine degradation. The obtained metabolomic data correlated with previous proteomic findings of the SVIP parasites and the gene expression of 13 selected targets. Late SIVP cultures were more sensitive to Sb
III produced more ROS and exposed less phosphatidylserine in their surface. The correspondent pathways were connected to build a biochemical map of the most significant alterations involved with the process of attenuation of L. amazonensis . Overall, the reported data pointed out to a very dynamic and continuous metabolic reprogramming process, accompanied by changes in energetic, lipid and redox metabolisms, membrane remodeling and reshaping of parasite-host cells interactions, causing impacts in chemotaxis, host inflammatory responses and infectivity at the early stages of infection., (Copyright © 2019 Crepaldi, de Toledo, do Carmo, Ferreira Marques Machado, de Brito, Serufo, Almeida, de Oliveira, Ricotta, Moreira, Murta, Diniz, Menezes, López-Gonzálvez, Barbas and Fernandes.)- Published
- 2019
- Full Text
- View/download PDF
14. An unusual case of tracheo-pleural fistula and cardiac metastases in oropharyngeal carcinoma: a case report and review of the literature.
- Author
-
Ferrari D, Codecà C, Viale G, Bocci B, Broggio F, Crepaldi F, Violati M, Luciani A, Bauer D, Moneghini L, Bulfamante G, and Foa P
- Abstract
Background: Oropharyngeal cancer is frequently associated with human papilloma virus, that also represents a strong prognostic factor. Local relaps and treatment-related complications are frequent, whereas distant metastases occur in about 25% of patients., Case Presentation: A 49 years-old male presented with a loco-regionally advanced oropharyngeal squamous cell carcinoma and was treated with concomitant chemoradiation. A complete clinical and pathological response was achieved, but the occurrence of necrotising tracheo-esophagitis, with tracheo-mediastino-pleural fistula formation, further complicated the subsequent clinical course. The patient died suddenly. Autopsy revealed multiple myocardial and epicardial metastases from oropharyngeal squamous cell carcinoma., Conclusions: Even in case of a transient complete local response, the potential occurrence of severe complications and distant metastases, although infrequent, should be considered. Cardiac metastases are frequently underestimated, as they are often asymptomatic, but may lead to sudden death. Further efforts are needed to improve diagnosis and therapy in this setting., Competing Interests: The authors declare that they have no competing interest.
- Published
- 2016
- Full Text
- View/download PDF
15. Anti-epidermal growth factor receptor skin toxicity: a matter of topical hydration.
- Author
-
Ferrari D, Codecà C, Bocci B, Crepaldi F, Violati M, Viale G, Careri C, Caldiera S, Bordin V, Luciani A, Zonato S, Cassinelli G, and Foa P
- Subjects
- Bevacizumab administration & dosage, Cetuximab administration & dosage, Colorectal Neoplasms pathology, Female, Humans, Middle Aged, Neoplasm Metastasis, Antineoplastic Combined Chemotherapy Protocols adverse effects, Colorectal Neoplasms drug therapy, ErbB Receptors antagonists & inhibitors, Exanthema therapy, Skin drug effects, Skin Cream therapeutic use
- Abstract
Skin toxicity is a frequent complication of anti-epidermal growth factor receptor therapy, which can be an obstacle in maintaining the dose intensity and may negatively impact on the clinical outcome of cancer patients. Skin lesions depend on the disruption of the keratinocyte development pathways and no treatment is clearly effective in resolving the cutaneous alterations frequently found during anti-epidermal growth factor receptor therapy. Among systemic treatments, oral tetracycline proved to be useful in preventing skin manifestations. We describe the case of a patient affected by metastatic colorectal cancer, for whom a combination of chemotherapy and cetuximab was used as second-line treatment. The patient developed a symptomatic papulopustular skin rash that disappeared completely after a twice-daily application of a hydrating and moisturizing cream, mainly consisting of a mixture of paraffin, silicone compounds, and macrogol. The marked cutaneous amelioration allowed the patient to continue cetuximab without any further symptoms and was associated with a partial radiological response.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.